240.19

2.85% 6.885

Lam Research Corp (LRCX)

Overview News Price History Option Chain Financials Why LRCX Down? Discussions Forecast Stock Split Dividend History

Lam Research Corp stock is traded at $240.19, with a volume of 4.29M. It is up +2.85% in the last 24 hours and down -1.76% over the past month. Lam Research is one of the largest semiconductor wafer fabrication equipment manufacturers in the world. It specializes in deposition and etch, which entail the buildup of layers on a semiconductor and the subsequent selective removal of patterns from each layer. Lam holds the top market share in etch and holds the clear second share in deposition. It is more exposed to memory chipmakers for DRAM and NAND chips. It counts as top customers the largest chipmakers in the world, including TSMC, Samsung, Intel, and Micron.

Previous Close:

$233.31

Open:

$230.16

24h Volume:

4.29M

Relative Volume:

0.37

Market Cap:

$299.74B

Revenue:

$20.56B

Net Income/Loss:

$6.21B

P/E Ratio:

49.23

EPS:

4.8791

Net Cash Flow:

$6.22B

1W Performance:

+5.96%

1M Performance:

-1.76%

6M Performance:

+87.00%

1Y Performance:

+207.68%

1-Day Range:

$230.16

$241.37

1-Week Range:

$215.00

$241.37

52-Week Range:

$56.32

$256.68

Lam Research Corp Stock (LRCX) Company Profile

Name

Lam Research Corp

Sector

Technology (777)

Industry

Semiconductor Equipment & Materials (29)

Phone

(510) 659-0200

Address

4650 CUSHING BLVD, FREMONT, CA

Employee

19,700

Twitter

@lamresearch

Next Earnings Date

2026-04-22

Latest SEC Filings

LRCX's Discussions on Twitter

Compare LRCX vs ASML, AMAT, KLAC, TER

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LRCX Lam Research Corp	240.03	291.35B	20.56B	6.21B	6.22B	4.8791
ASML Asml Holding Nv	1,402.09	527.88B	36.97B	10.86B	12.49B	27.95
AMAT Applied Materials Inc	376.62	287.12B	28.21B	7.84B	6.19B	9.7629
KLAC Kla Corp	1,569.49	198.11B	12.74B	4.56B	4.38B	34.42
TER Teradyne Inc	320.73	47.58B	3.19B	554.05M	450.41M	3.483

Lam Research Corp Stock (LRCX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-29-26	Upgrade	Summit Insights	Hold → Buy
Jan-29-26	Reiterated	TD Cowen	Buy
Jan-15-26	Initiated	RBC Capital Mkts	Outperform
Jan-15-26	Upgrade	Wells Fargo	Equal Weight → Overweight
Oct-23-25	Reiterated	TD Cowen	Buy
Sep-30-25	Initiated	HSBC Securities	Hold
Sep-29-25	Upgrade	Deutsche Bank	Hold → Buy
Sep-23-25	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Sep-22-25	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Sep-02-25	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Aug-14-25	Resumed	Erste Group	Buy
Jul-31-25	Downgrade	Summit Insights	Buy → Hold
Jul-31-25	Reiterated	TD Cowen	Buy
Jul-10-25	Initiated	Goldman	Buy
Apr-24-25	Reiterated	TD Cowen	Buy
Mar-20-25	Resumed	Oppenheimer	Outperform
Feb-20-25	Upgrade	Susquehanna	Neutral → Positive
Jan-30-25	Upgrade	Bernstein	Mkt Perform → Outperform
Jan-30-25	Upgrade	Cantor Fitzgerald	Neutral → Overweight
Jan-17-25	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Jan-15-25	Downgrade	Wolfe Research	Outperform → Peer Perform
Dec-17-24	Initiated	Cleveland Research	Neutral
Aug-01-24	Reiterated	TD Cowen	Buy
May-13-24	Initiated	Jefferies	Buy
Apr-25-24	Reiterated	TD Cowen	Buy
Apr-19-24	Upgrade	B. Riley Securities	Neutral → Buy
Apr-18-24	Reiterated	Needham	Buy
Apr-16-24	Initiated	Evercore ISI	Outperform
Apr-11-24	Resumed	Deutsche Bank	Hold
Jan-25-24	Reiterated	TD Cowen	Outperform
Jan-23-24	Initiated	Cantor Fitzgerald	Neutral
Dec-12-23	Downgrade	Deutsche Bank	Buy → Hold
Dec-08-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Nov-22-23	Initiated	Redburn Atlantic	Buy
Oct-17-23	Initiated	Raymond James	Outperform
Oct-13-23	Upgrade	Needham	Hold → Buy
Sep-15-23	Initiated	Wolfe Research	Outperform
Jul-24-23	Reiterated	Mizuho	Buy
Jul-24-23	Upgrade	Stifel	Hold → Buy
Apr-20-23	Reiterated	Berenberg	Buy
Apr-20-23	Reiterated	Evercore ISI	Outperform
Apr-20-23	Reiterated	JP Morgan	Overweight
Apr-20-23	Reiterated	Jefferies	Buy
Apr-20-23	Reiterated	Mizuho	Buy
Apr-20-23	Reiterated	Stifel	Hold
Apr-20-23	Reiterated	Wells Fargo	Equal Weight
Mar-13-23	Downgrade	Bernstein	Outperform → Mkt Perform
Jan-18-23	Resumed	Stifel	Hold
Dec-12-22	Upgrade	Deutsche Bank	Hold → Buy
Oct-20-22	Reiterated	B. Riley Securities	Neutral
Oct-20-22	Reiterated	BofA Securities	Buy
Oct-20-22	Reiterated	DA Davidson	Neutral
Oct-20-22	Reiterated	Evercore ISI	Outperform
Oct-20-22	Reiterated	JP Morgan	Overweight
Oct-20-22	Reiterated	Jefferies	Buy
Oct-20-22	Upgrade	Summit Insights	Hold → Buy
Oct-20-22	Reiterated	Wells Fargo	Equal Weight
Jul-25-22	Downgrade	Barclays	Overweight → Equal Weight
Jun-15-22	Downgrade	B. Riley Securities	Buy → Neutral
Jan-27-22	Reiterated	Barclays	Overweight
Jan-27-22	Reiterated	Deutsche Bank	Hold
Jan-27-22	Reiterated	Evercore ISI	Outperform
Jan-27-22	Reiterated	Stifel	Buy
Jan-27-22	Reiterated	Susquehanna	Neutral
Jan-27-22	Reiterated	UBS	Buy
Jan-26-22	Initiated	KeyBanc Capital Markets	Sector Weight
Jan-12-22	Reiterated	Barclays	Overweight
Jan-10-22	Reiterated	BofA Securities	Buy
Jan-05-22	Resumed	Jefferies	Buy
Dec-15-21	Reiterated	Deutsche Bank	Hold
Oct-21-21	Reiterated	B. Riley Securities	Buy
Oct-21-21	Downgrade	Summit Insights	Buy → Hold
Oct-15-21	Initiated	Piper Sandler	Neutral
Sep-14-21	Downgrade	Susquehanna	Positive → Neutral
Sep-07-21	Downgrade	Exane BNP Paribas	Outperform → Neutral
Jul-29-21	Reiterated	Mizuho	Buy
Jul-29-21	Reiterated	Stifel	Buy
Jul-29-21	Reiterated	UBS	Buy
Jul-29-21	Reiterated	Wells Fargo	Equal Weight
Mar-31-21	Initiated	Bernstein	Outperform
Jan-28-21	Reiterated	Cowen	Outperform
Jan-08-21	Downgrade	Needham	Buy → Hold
Dec-17-20	Downgrade	Deutsche Bank	Buy → Hold
Oct-22-20	Reiterated	Goldman	Buy
Oct-22-20	Reiterated	KeyBanc Capital Markets	Overweight
Oct-22-20	Reiterated	Mizuho	Buy
Oct-22-20	Reiterated	Morgan Stanley	Overweight
Oct-22-20	Reiterated	RBC Capital Mkts	Outperform
Oct-22-20	Reiterated	Stifel	Buy
Oct-22-20	Reiterated	UBS	Buy
Sep-21-20	Upgrade	Stifel	Hold → Buy
Jul-30-20	Reiterated	Cowen	Outperform
Jul-21-20	Upgrade	B. Riley FBR	Neutral → Buy
Jun-22-20	Downgrade	Stifel	Buy → Hold
Jun-16-20	Upgrade	Morgan Stanley	Equal-Weight → Overweight
May-26-20	Initiated	Barclays	Overweight
Apr-23-20	Reiterated	Needham	Buy
Apr-08-20	Initiated	Exane BNP Paribas	Outperform
Apr-03-20	Upgrade	Nomura	Neutral → Buy
Apr-02-20	Downgrade	DA Davidson	Buy → Neutral
Mar-27-20	Upgrade	Deutsche Bank	Hold → Buy
Mar-27-20	Upgrade	UBS	Sell → Buy

View All

Lam Research Corp Stock (LRCX) Latest News

10:30 AM

Jim Cramer on Lam Research: “You’ve Got a Winner in Lam Research” - Insider Monkey

10:30 AM

Mar 23, 2026